Pathophysiological pathway differences in children who present with COVID-19 ARDS compared to COVID -19 induced MIS-C.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
02 05 2022
Historique:
received: 12 02 2021
accepted: 08 04 2022
entrez: 2 5 2022
pubmed: 3 5 2022
medline: 6 5 2022
Statut: epublish

Résumé

COVID-19 has infected more than 275 million worldwide (at the beginning of 2022). Children appear less susceptible to COVID-19 and present with milder symptoms. Cases of children with COVID-19 developing clinical features of Kawasaki-disease have been described. Here we utilise Mass Spectrometry proteomics to determine the plasma proteins expressed in healthy children pre-pandemic, children with multisystem inflammatory syndrome (MIS-C) and children with COVID-19 induced ARDS. Pathway analyses were performed to determine the affected pathways. 76 proteins are differentially expressed across the groups, with 85 and 52 proteins specific to MIS-C and COVID-19 ARDS, respectively. Complement and coagulation activation are implicated in these clinical phenotypes, however there was significant contribution of FcGR and BCR activation in MIS-C and scavenging of haem and retinoid metabolism in COVID-19 ARDS. We show global proteomic differences in MIS-C and COVID-ARDS, although both show complement and coagulation dysregulation. The results contribute to our understanding of MIS-C and COVID-19 ARDS in children.

Identifiants

pubmed: 35501302
doi: 10.1038/s41467-022-29951-9
pii: 10.1038/s41467-022-29951-9
pmc: PMC9061738
doi:

Substances chimiques

Complement System Proteins 9007-36-7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2391

Informations de copyright

© 2022. The Author(s).

Références

BMJ Open. 2019 Apr 3;9(4):e025897
pubmed: 30948591
JAMA. 2020 Jul 21;324(3):259-269
pubmed: 32511692
Med Hypotheses. 2020 Nov;144:110250
pubmed: 33254555
Blood Adv. 2020 Dec 8;4(23):6051-6063
pubmed: 33290544
Pediatr Crit Care Med. 2015 Jun;16(5):428-39
pubmed: 25647235
Lancet Child Adolesc Health. 2021 Feb;5(2):133-141
pubmed: 32956615
Proc Natl Acad Sci U S A. 2020 Oct 6;117(40):25018-25025
pubmed: 32943538
BMC Bioinformatics. 2017 Mar 2;18(1):142
pubmed: 28249561
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
N Engl J Med. 2020 Mar 5;382(10):970-971
pubmed: 32003551
Nucleic Acids Res. 2015 Jan;43(Database issue):D447-52
pubmed: 25352553
Clin Infect Dis. 2020 Sep 12;71(6):1547-1551
pubmed: 32112072
Indian J Pediatr. 2020 Apr;87(4):281-286
pubmed: 32166607
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):422-426
pubmed: 32271728
Front Immunol. 2015 Jan 21;5:674
pubmed: 25653650
IUBMB Life. 2005 Nov;57(11):749-59
pubmed: 16511968
BMJ. 2020 Jun 3;369:m2094
pubmed: 32493739
Mol Cell Proteomics. 2016 Jul;15(7):2501-14
pubmed: 27161445
J Thromb Haemost. 2020 Apr;18(4):844-847
pubmed: 32073213
Lancet. 2020 May 23;395(10237):1607-1608
pubmed: 32386565
Pediatr Cardiol. 2020 Oct;41(7):1391-1401
pubmed: 32529358
Virology. 2015 May;479-480:110-21
pubmed: 25749629
DNA Cell Biol. 2002 Apr;21(4):271-80
pubmed: 12042067
N Engl J Med. 2020 Apr 23;382(17):1663-1665
pubmed: 32187458
Pediatr Infect Dis J. 1996 Sep;15(9):782-6
pubmed: 8878221
Ann Intensive Care. 2020 Jun 1;10(1):69
pubmed: 32488505
Ann Rheum Dis. 2020 Aug;79(8):999-1006
pubmed: 32527868
Lancet. 2020 Jun 6;395(10239):1771-1778
pubmed: 32410760
Pediatr Blood Cancer. 2020 Dec;67(12):e28737
pubmed: 33098753
Am J Physiol Lung Cell Mol Physiol. 2016 Oct 1;311(4):L714-L718
pubmed: 27542810
China CDC Wkly. 2020 Feb 21;2(8):113-122
pubmed: 34594836
J Immunol. 2002 Apr 1;168(7):3502-6
pubmed: 11907111
Cell Syst. 2020 Jul 22;11(1):11-24.e4
pubmed: 32619549
J Pediatr. 2020 Sep;224:141-145
pubmed: 32553873
Cell. 2020 Jul 9;182(1):59-72.e15
pubmed: 32492406
Circulation. 2020 Aug 4;142(5):429-436
pubmed: 32418446
Hosp Pediatr. 2020 Jun;10(6):537-540
pubmed: 32265235

Auteurs

Conor McCafferty (C)

Haematology Research, Murdoch Children's Research Institute, Melbourne, VIC, Australia.
Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia.

Tengyi Cai (T)

Haematology Research, Murdoch Children's Research Institute, Melbourne, VIC, Australia.

Delphine Borgel (D)

Department of Biological Hematology, Necker Hospital, AP-HP, F-75015, Paris, France.

Dominique Lasne (D)

Department of Biological Hematology, Necker Hospital, AP-HP, F-75015, Paris, France.

Sylvain Renolleau (S)

Pediatric Intensive Care Unit, Necker Hospital AP-HP, F-75015, Paris, France.

Meryl Vedrenne-Cloquet (M)

Pediatric Intensive Care Unit, Necker Hospital AP-HP, F-75015, Paris, France.

Damien Bonnet (D)

M3C-Necker, Congenital and Pediatric Cardiology, Necker Hospital, AP-HP, F-75015, Paris, France.

Jemma Wu (J)

Australian Proteome Analysis Facility, Sydney, NSW, Australia.

Thiri Zaw (T)

Australian Proteome Analysis Facility, Sydney, NSW, Australia.

Atul Bhatnagar (A)

Australian Proteome Analysis Facility, Sydney, NSW, Australia.

Xiaomin Song (X)

Australian Proteome Analysis Facility, Sydney, NSW, Australia.

Suelyn Van Den Helm (S)

Haematology Research, Murdoch Children's Research Institute, Melbourne, VIC, Australia.

Natasha Letunica (N)

Haematology Research, Murdoch Children's Research Institute, Melbourne, VIC, Australia.

Chantal Attard (C)

Haematology Research, Murdoch Children's Research Institute, Melbourne, VIC, Australia.
Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia.

Vasiliki Karlaftis (V)

Haematology Research, Murdoch Children's Research Institute, Melbourne, VIC, Australia.

Slavica Praporski (S)

Haematology Research, Murdoch Children's Research Institute, Melbourne, VIC, Australia.

Vera Ignjatovic (V)

Haematology Research, Murdoch Children's Research Institute, Melbourne, VIC, Australia. vera.ignjatovic@mcri.edu.au.
Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia. vera.ignjatovic@mcri.edu.au.

Paul Monagle (P)

Haematology Research, Murdoch Children's Research Institute, Melbourne, VIC, Australia.
Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia.
Department of Clinical Haematology, Royal Children's Hospital, Melbourne, VIC, Australia.
Kids Cancer Centre, Sydney Children's Hospital, Randwick, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH